A platform that creates antibodies targeting drug-peptide conjugates presented by MHC molecules on cancer cells to enable immune system recognition and killing of drug-resistant tumor cells.

Antibodies engineered to bind drug-peptide conjugates presented on MHC molecules of cancer cells, facilitating immune-mediated elimination of drug-resistant tumor cells.